spacer
spacer

PDBsum entry 1ak4

Go to PDB code: 
protein Protein-protein interface(s) links
Viral protein/isomerase PDB id
1ak4
Jmol
Contents
Protein chains
165 a.a. *
145 a.a. *
Waters ×321
* Residue conservation analysis
PDB id:
1ak4
Name: Viral protein/isomerase
Title: Human cyclophilin a bound to the amino-terminal domain of HIV-1 capsid
Structure: Cyclophilin a. Chain: a, b. Engineered: yes. HIV-1 capsid. Chain: c, d. Fragment: n-terminal domain. Engineered: yes. Mutation: yes
Source: Homo sapiens. Human. Organism_taxid: 9606. Cell_line: bl21. Gene: cyclophilin. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Human immunodeficiency virus 1. Organism_taxid: 11676.
Biol. unit: Monomer (from PDB file)
Resolution:
2.36Å     R-factor:   0.238     R-free:   0.306
Authors: C.P.Hill,T.R.Gamble,F.F.Vajdos,D.K.Worthylake,W.I.Sundquist
Key ref:
T.R.Gamble et al. (1996). Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell, 87, 1285-1294. PubMed id: 8980234 DOI: 10.1016/S0092-8674(00)81823-1
Date:
28-May-97     Release date:   15-Oct-97    
PROCHECK
Go to PROCHECK summary
 Headers
 References

Protein chains
Pfam   ArchSchema ?
P62937  (PPIA_HUMAN) -  Peptidyl-prolyl cis-trans isomerase A
Seq:
Struc:
165 a.a.
165 a.a.
Protein chains
Pfam   ArchSchema ?
P12497  (POL_HV1N5) -  Gag-Pol polyprotein
Seq:
Struc:
 
Seq:
Struc:
 
Seq:
Struc:
1435 a.a.
145 a.a.
Key:    PfamA domain  Secondary structure  CATH domain

 Enzyme reactions 
   Enzyme class 1: Chains A, B: E.C.5.2.1.8  - Peptidylprolyl isomerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Peptidylproline (omega=180) = peptidylproline (omega=0)
Peptidylproline (omega=180)
= peptidylproline (omega=0)
   Enzyme class 2: Chains C, D: E.C.2.7.7.49  - RNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1)
Deoxynucleoside triphosphate
+ DNA(n)
= diphosphate
+ DNA(n+1)
   Enzyme class 3: Chains C, D: E.C.2.7.7.7  - DNA-directed Dna polymerase.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Deoxynucleoside triphosphate + DNA(n) = diphosphate + DNA(n+1)
Deoxynucleoside triphosphate
+ DNA(n)
= diphosphate
+ DNA(n+1)
   Enzyme class 4: Chains C, D: E.C.3.1.13.2  - Exoribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Exonucleolytic cleavage to 5'-phosphomonoester oligonucleotides in both 5'- to 3'- and 3'- to 5'-directions.
   Enzyme class 5: Chains C, D: E.C.3.1.26.13  - Retroviral ribonuclease H.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
   Enzyme class 6: Chains C, D: E.C.3.4.23.16  - HIV-1 retropepsin.
[IntEnz]   [ExPASy]   [KEGG]   [BRENDA]
      Reaction: Specific for a P1 residue that is hydrophobic, and P1' variable, but often Pro.
Note, where more than one E.C. class is given (as above), each may correspond to a different protein domain or, in the case of polyprotein precursors, to a different mature protein.
Molecule diagrams generated from .mol files obtained from the KEGG ftp site
 Gene Ontology (GO) functional annotation 
  GO annot!
  Cellular component     extracellular region   8 terms 
  Biological process     viral reproduction   18 terms 
  Biochemical function     protein binding     7 terms  

 

 
    reference    
 
 
DOI no: 10.1016/S0092-8674(00)81823-1 Cell 87:1285-1294 (1996)
PubMed id: 8980234  
 
 
Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid.
T.R.Gamble, F.F.Vajdos, S.Yoo, D.K.Worthylake, M.Houseweart, W.I.Sundquist, C.P.Hill.
 
  ABSTRACT  
 
The HIV-1 capsid protein forms the conical core structure at the center of the mature virion. Capsid also binds the human peptidyl prolyl isomerase, cyclophilin A, thereby packaging the enzyme into the virion. Cyclophilin A subsequently performs an essential function in HIV-1 replication, possibly helping to disassemble the capsid core upon infection. We report the 2.36 A crystal structure of the N-terminal domain of HIV-1 capsid (residues 1-151) in complex with human cyclophilin A. A single exposed capsid loop (residues 85-93) binds in the enzyme's active site, and Pro-90 adopts an unprecedented trans conformation. The structure suggests how cyclophilin A can act as a sequence-specific binding protein and a nonspecific prolyl isomerase. In the crystal lattice, capsid molecules assemble into continuous planar strips. Side by side association of these strips may allow capsid to form the surface of the viral core. Cyclophilin A could then function by weakening the association between capsid strips, thereby promoting disassembly of the viral core.
 
  Selected figure(s)  
 
Figure 2.
Figure 2. Interaction between CA[151] and CypA(A) Ribbon diagram of the CA[151]/CypA complex: orientation of CA[151] is similar to that of (1B), and the same color code is used. CypA β strands are shown in red and helices are in green.(B) Tube representation of the CA[151]/CypA complex: orientation is perpendicular to (1B). Both complexes in the asymmetric unit are shown following superposition on the two CypA molecules. Complex 1 is shown in cyan (CA[151]-1) and green (CypA-1), and complex 2 is in magenta (CA[151]-2) and red (CypA-2). Figure 2, Figure 4, and 5 were prepared with MIDASPLUS ( [16]).
Figure 3.
Figure 3. Molecular Recognition between CA[151] and CypASchematic representation of the CA[151] and CypA interface ([55]). Hydrogen bonding interactions are shown when the acceptor-to-donor distance is 3.4 Å or less in one of the two complexes. Van der Waals interactions are defined as contacts of 4.1 Å or less in one of the two complexes.
 
  The above figures are reprinted by permission from Cell Press: Cell (1996, 87, 1285-1294) copyright 1996.  
  Figures were selected by an automated process.  

Literature references that cite this PDB file's key reference

  PubMed id Reference
22421880 A.Engelman, and P.Cherepanov (2012).
The structural biology of HIV-1: mechanistic and therapeutic insights.
  Nat Rev Microbiol, 10, 279-290.  
22407016 M.E.Caines, K.Bichel, A.J.Price, W.A.McEwan, G.J.Towers, B.J.Willett, S.M.Freund, and L.C.James (2012).
Diverse HIV viruses are targeted by a conformationally dynamic antiviral.
  Nat Struct Mol Biol, 19, 411-416.
PDB codes: 4dga 4dgb 4dgc 4dgd 4dge
21187419 B.K.Ganser-Pornillos, V.Chandrasekaran, O.Pornillos, J.G.Sodroski, W.I.Sundquist, and M.Yeager (2011).
Hexagonal assembly of a restricting TRIM5alpha protein.
  Proc Natl Acad Sci U S A, 108, 534-539.  
20602248 A.Galat, and J.Bua (2010).
Molecular aspects of cyclophilins mediating therapeutic actions of their ligands.
  Cell Mol Life Sci, 67, 3467-3488.  
  20808775 A.Kirmaier, F.Wu, R.M.Newman, L.R.Hall, J.S.Morgan, S.O'Connor, P.A.Marx, M.Meythaler, S.Goldstein, A.Buckler-White, A.Kaur, V.M.Hirsch, and W.E.Johnson (2010).
TRIM5 suppresses cross-species transmission of a primate immunodeficiency virus and selects for emergence of resistant variants in the new species.
  PLoS Biol, 8, 0.  
20095046 B.Chen, and R.Tycko (2010).
Structural and dynamical characterization of tubular HIV-1 capsid protein assemblies by solid state nuclear magnetic resonance and electron microscopy.
  Protein Sci, 19, 716-730.  
19910057 B.G.Luttge, and E.O.Freed (2010).
FIV Gag: virus assembly and host-cell interactions.
  Vet Immunol Immunopathol, 134, 3.  
19782103 C.S.Adamson, and E.O.Freed (2010).
Novel approaches to inhibiting HIV-1 replication.
  Antiviral Res, 85, 119-141.  
20808866 L.M.Ylinen, A.J.Price, J.Rasaiyaah, S.Hué, N.J.Rose, F.Marzetta, L.C.James, and G.J.Towers (2010).
Conformational adaptation of Asian macaque TRIMCyp directs lineage specific antiviral activity.
  PLoS Pathog, 6, 0.
PDB codes: 2x82 2x83
20364129 M.Lammers, H.Neumann, J.W.Chin, and L.C.James (2010).
Acetylation regulates cyclophilin A catalysis, immunosuppression and HIV isomerization.
  Nat Chem Biol, 6, 331-337.
PDB codes: 2x25 2x2a 2x2c 2x2d
20219923 M.S.Briones, C.W.Dobard, and S.A.Chow (2010).
Role of human immunodeficiency virus type 1 integrase in uncoating of the viral core.
  J Virol, 84, 5181-5190.  
20721640 M.S.Briones, and S.A.Chow (2010).
A new functional role of HIV-1 integrase during uncoating of the viral core.
  Immunol Res, 48, 14-26.  
20920334 S.M.Solbak, T.R.Reksten, V.Wray, K.Bruns, O.Horvli, A.J.Raae, P.Henklein, P.Henklein, R.Röder, D.Mitzner, U.Schubert, and T.Fossen (2010).
The intriguing cyclophilin A-HIV-1 Vpr interaction: prolyl cis/trans isomerisation catalysis and specific binding.
  BMC Struct Biol, 10, 31.  
20529865 S.Misumi, M.Inoue, T.Dochi, N.Kishimoto, N.Hasegawa, N.Takamune, and S.Shoji (2010).
Uncoating of human immunodeficiency virus type 1 requires prolyl isomerase Pin1.
  J Biol Chem, 285, 25185-25195.  
21170360 W.S.Blair, C.Pickford, S.L.Irving, D.G.Brown, M.Anderson, R.Bazin, J.Cao, G.Ciaramella, J.Isaacson, L.Jackson, R.Hunt, A.Kjerrstrom, J.A.Nieman, A.K.Patick, M.Perros, A.D.Scott, K.Whitby, H.Wu, and S.L.Butler (2010).
HIV capsid is a tractable target for small molecule therapeutic intervention.
  PLoS Pathog, 6, e1001220.
PDB code: 2xde
20089655 X.Tian, C.Zhao, H.Zhu, W.She, J.Zhang, J.Liu, L.Li, S.Zheng, Y.M.Wen, and Y.Xie (2010).
Hepatitis B virus (HBV) surface antigen interacts with and promotes cyclophilin a secretion: possible link to pathogenesis of HBV infection.
  J Virol, 84, 3373-3381.  
20092249 Y.Han, J.Ahn, J.Concel, I.J.Byeon, A.M.Gronenborn, J.Yang, and T.Polenova (2010).
Solid-state NMR studies of HIV-1 capsid protein assemblies.
  J Am Chem Soc, 132, 1976-1987.  
19767750 A.J.Price, F.Marzetta, M.Lammers, L.M.Ylinen, T.Schaller, S.J.Wilson, G.J.Towers, and L.C.James (2009).
Active site remodeling switches HIV specificity of antiretroviral TRIMCyp.
  Nat Struct Mol Biol, 16, 1036-1042.
PDB codes: 2wlv 2wlw
19680534 A.Kaul, S.Stauffer, C.Berger, T.Pertel, J.Schmitt, S.Kallis, M.Z.Lopez, V.Lohmann, J.Luban, and R.Bartenschlager (2009).
Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics.
  PLoS Pathog, 5, e1000546.  
19825046 A.P.Mascarenhas, and K.Musier-Forsyth (2009).
The capsid protein of human immunodeficiency virus: interactions of HIV-1 capsid with host protein factors.
  FEBS J, 276, 6118-6127.  
19534569 C.S.Adamson, K.Salzwedel, and E.O.Freed (2009).
Virus maturation as a new HIV-1 therapeutic target.
  Expert Opin Ther Targets, 13, 895-908.  
19128175 D.Hamelberg, and J.A.McCammon (2009).
Mechanistic insight into the role of transition-state stabilization in cyclophilin A.
  J Am Chem Soc, 131, 147-152.  
19356593 E.Barklis, A.Alfadhli, C.McQuaw, S.Yalamuri, A.Still, R.L.Barklis, B.Kukull, and C.S.López (2009).
Characterization of the in vitro HIV-1 capsid assembly pathway.
  J Mol Biol, 387, 376-389.  
19478882 F.D.Bushman, N.Malani, J.Fernandes, I.D'Orso, G.Cagney, T.L.Diamond, H.Zhou, D.J.Hazuda, A.S.Espeseth, R.König, S.Bandyopadhyay, T.Ideker, S.P.Goff, N.J.Krogan, A.D.Frankel, J.A.Young, and S.K.Chanda (2009).
Host cell factors in HIV replication: meta-analysis of genome-wide studies.
  PLoS Pathog, 5, e1000437.  
19194444 G.Cardone, J.G.Purdy, N.Cheng, R.C.Craven, and A.C.Steven (2009).
Visualization of a missing link in retrovirus capsid assembly.
  Nature, 457, 694-698.  
19914170 I.J.Byeon, X.Meng, J.Jung, G.Zhao, R.Yang, J.Ahn, J.Shi, J.Concel, C.Aiken, P.Zhang, and A.M.Gronenborn (2009).
Structural convergence between Cryo-EM and NMR reveals intersubunit interactions critical for HIV-1 capsid function.
  Cell, 139, 780-790.
PDB code: 2kod
19825045 J.L.Neira (2009).
The capsid protein of human immunodeficiency virus: designing inhibitors of capsid assembly.
  FEBS J, 276, 6110-6117.  
19319933 J.Schlegel, G.S.Armstrong, J.S.Redzic, F.Zhang, and E.Z.Eisenmesser (2009).
Characterizing and controlling the inherent dynamics of cyclophilin-A.
  Protein Sci, 18, 811-824.  
19176623 M.Aoki, D.J.Venzon, Y.Koh, H.Aoki-Ogata, T.Miyakawa, K.Yoshimura, K.Maeda, and H.Mitsuya (2009).
Non-cleavage site gag mutations in amprenavir-resistant human immunodeficiency virus type 1 (HIV-1) predispose HIV-1 to rapid acquisition of amprenavir resistance but delay development of resistance to other protease inhibitors.
  J Virol, 83, 3059-3068.  
19455277 N.Sakamoto, and M.Watanabe (2009).
New therapeutic approaches to hepatitis C virus.
  J Gastroenterol, 44, 643-649.  
  19356241 S.Abdurahman, A.Végvári, M.Levi, S.Höglund, M.Högberg, W.Tong, I.Romero, J.Balzarini, and A.Vahlne (2009).
Isolation and characterization of a small antiretroviral molecule affecting HIV-1 capsid morphology.
  Retrovirology, 6, 34.  
  19254360 S.Matsuoka, E.Dam, D.Lecossier, F.Clavel, and A.J.Hance (2009).
Modulation of HIV-1 infectivity and cyclophilin A-dependence by Gag sequence and target cell type.
  Retrovirology, 6, 21.  
19116253 T.Miura, M.A.Brockman, A.Schneidewind, M.Lobritz, F.Pereyra, A.Rathod, B.L.Block, Z.L.Brumme, C.J.Brumme, B.Baker, A.C.Rothchild, B.Li, A.Trocha, E.Cutrell, N.Frahm, C.Brander, I.Toth, E.J.Arts, T.M.Allen, and B.D.Walker (2009).
HLA-B57/B*5801 human immunodeficiency virus type 1 elite controllers select for rare gag variants associated with reduced viral replication capacity and strong cytotoxic T-lymphotye recognition.
  J Virol, 83, 2743-2755.  
19262010 T.Nagao, K.Hatcho, N.Doi, S.Fujiwara, A.Adachi, and M.Nomaguchi (2009).
Amino acid alterations in Gag that confer the ability to grow in simian cells on HIV-1 are located at a narrow CA region.
  J Med Invest, 56, 21-25.  
19199580 X.Yu, Q.Wang, J.C.Yang, I.Buch, C.J.Tsai, B.Ma, S.Z.Cheng, R.Nussinov, and J.Zheng (2009).
Mutational analysis and allosteric effects in the HIV-1 capsid protein carboxyl-terminal dimerization domain.
  Biomacromolecules, 10, 390-399.  
19903261 Y.Kitagawa, M.Maeda-Sato, K.Tanaka, M.Tobiume, H.Sawa, H.Hasegawa, A.Kojima, W.W.Hall, T.Kurata, T.Sata, and H.Takahashi (2009).
Covalent bonded Gag multimers in human immunodeficiency virus type-1 particles.
  Microbiol Immunol, 53, 609-620.  
19656870 Y.Li, A.K.Kar, and J.Sodroski (2009).
Target cell type-dependent modulation of human immunodeficiency virus type 1 capsid disassembly by cyclophilin A.
  J Virol, 83, 10951-10962.  
18385228 A.Schneidewind, M.A.Brockman, J.Sidney, Y.E.Wang, H.Chen, T.J.Suscovich, B.Li, R.I.Adam, R.L.Allgaier, B.R.Mothé, T.Kuntzen, C.Oniangue-Ndza, A.Trocha, X.G.Yu, C.Brander, A.Sette, B.D.Walker, and T.M.Allen (2008).
Structural and functional constraints limit options for cytotoxic T-lymphocyte escape in the immunodominant HLA-B27-restricted epitope in human immunodeficiency virus type 1 capsid.
  J Virol, 82, 5594-5605.  
18406133 B.K.Ganser-Pornillos, M.Yeager, and W.I.Sundquist (2008).
The structural biology of HIV assembly.
  Curr Opin Struct Biol, 18, 203-217.  
18287034 C.A.Virgen, Z.Kratovac, P.D.Bieniasz, and T.Hatziioannou (2008).
Independent genesis of chimeric TRIM5-cyclophilin proteins in two primate species.
  Proc Natl Acad Sci U S A, 105, 3563-3568.  
18799573 C.R.Langelier, V.Sandrin, D.M.Eckert, D.E.Christensen, V.Chandrasekaran, S.L.Alam, C.Aiken, J.C.Olsen, A.K.Kar, J.G.Sodroski, and W.I.Sundquist (2008).
Biochemical characterization of a recombinant TRIM5alpha protein that restricts human immunodeficiency virus type 1 replication.
  J Virol, 82, 11682-11694.  
18385230 F.Yang, J.M.Robotham, H.B.Nelson, A.Irsigler, R.Kenworthy, and H.Tang (2008).
Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro.
  J Virol, 82, 5269-5278.  
18057233 H.O.Peters, M.G.Mendoza, R.E.Capina, M.Luo, X.Mao, M.Gubbins, N.J.Nagelkerke, I.Macarthur, B.B.Sheardown, J.Kimani, C.Wachihi, S.Thavaneswaran, and F.A.Plummer (2008).
An integrative bioinformatic approach for studying escape mutations in human immunodeficiency virus type 1 gag in the Pumwani Sex Worker Cohort.
  J Virol, 82, 1980-1992.  
18577167 H.Takeuchi, and T.Matano (2008).
Host factors involved in resistance to retroviral infection.
  Microbiol Immunol, 52, 318-325.  
18443296 J.A.Readinger, G.M.Schiralli, J.K.Jiang, C.J.Thomas, A.August, A.J.Henderson, and P.L.Schwartzberg (2008).
Selective targeting of ITK blocks multiple steps of HIV replication.
  Proc Natl Acad Sci U S A, 105, 6684-6689.  
18489586 L.A.Alcaraz, M.Del Alamo, M.G.Mateu, and J.L.Neira (2008).
Structural mobility of the monomeric C-terminal domain of the HIV-1 capsid protein.
  FEBS J, 275, 3299-3311.  
  18613956 L.Carthagena, M.C.Parise, M.Ringeard, M.K.Chelbi-Alix, U.Hazan, and S.Nisole (2008).
Implication of TRIM alpha and TRIMCyp in interferon-induced anti-retroviral restriction activities.
  Retrovirology, 5, 59.  
19092998 M.A.Rits, K.A.van Dort, and N.A.Kootstra (2008).
Polymorphisms in the regulatory region of the Cyclophilin A gene influence the susceptibility for HIV-1 infection.
  PLoS ONE, 3, e3975.  
18191978 M.Qi, and C.Aiken (2008).
Nef enhances HIV-1 infectivity via association with the virus assembly complex.
  Virology, 373, 287-297.  
18829762 M.Qi, R.Yang, and C.Aiken (2008).
Cyclophilin A-dependent restriction of human immunodeficiency virus type 1 capsid mutants for infection of nondividing cells.
  J Virol, 82, 12001-12008.  
18275818 N.London, and O.Schueler-Furman (2008).
Funnel hunting in a rough terrain: learning and discriminating native energy funnels.
  Structure, 16, 269-279.  
18433823 P.M.Lokhandwala, T.L.Nguyen, J.B.Bowzard, and R.C.Craven (2008).
Cooperative role of the MHR and the CA dimerization helix in the maturation of the functional retrovirus capsid.
  Virology, 376, 191-198.  
18212100 R.G.Ptak, P.A.Gallay, D.Jochmans, A.P.Halestrap, U.T.Ruegg, L.A.Pallansch, M.D.Bobardt, M.P.de Béthune, J.Neyts, E.De Clercq, J.M.Dumont, P.Scalfaro, K.Besseghir, R.M.Wenger, and B.Rosenwirth (2008).
Inhibition of human immunodeficiency virus type 1 replication in human cells by Debio-025, a novel cyclophilin binding agent.
  Antimicrob Agents Chemother, 52, 1302-1317.  
  18605989 S.Brun, M.Solignat, B.Gay, E.Bernard, L.Chaloin, D.Fenard, C.Devaux, N.Chazal, and L.Briant (2008).
VSV-G pseudotyping rescues HIV-1 CA mutations that impair core assembly or stability.
  Retrovirology, 5, 57.  
18382677 S.K.Kyere, P.R.Joseph, and M.F.Summers (2008).
The p12 domain is unstructured in a murine leukemia virus p12-CA(N) Gag construct.
  PLoS ONE, 3, e1902.  
18305041 S.Kawada, T.Goto, H.Haraguchi, A.Ono, and Y.Morikawa (2008).
Dominant negative inhibition of human immunodeficiency virus particle production by the nonmyristoylated form of gag.
  J Virol, 82, 4384-4399.  
18678385 T.Y.Lin, and M.Emerman (2008).
Determinants of cyclophilin A-dependent TRIM5 alpha restriction against HIV-1.
  Virology, 379, 335-341.  
18385235 Y.Zhou, L.Rong, J.Lu, Q.Pan, and C.Liang (2008).
Insulin-like growth factor II mRNA binding protein 1 associates with Gag protein of human immunodeficiency virus type 1, and its overexpression affects virus assembly.
  J Virol, 82, 5683-5692.  
17804494 A.Schneidewind, M.A.Brockman, R.Yang, R.I.Adam, B.Li, S.Le Gall, C.R.Rinaldo, S.L.Craggs, R.L.Allgaier, K.A.Power, T.Kuntzen, C.S.Tung, M.X.LaBute, S.M.Mueller, T.Harrer, A.J.McMichael, P.J.Goulder, C.Aiken, C.Brander, A.D.Kelleher, and T.M.Allen (2007).
Escape from the dominant HLA-B27-restricted cytotoxic T-lymphocyte response in Gag is associated with a dramatic reduction in human immunodeficiency virus type 1 replication.
  J Virol, 81, 12382-12393.  
17923088 B.K.Ganser-Pornillos, A.Cheng, and M.Yeager (2007).
Structure of full-length HIV-1 CA: a model for the mature capsid lattice.
  Cell, 131, 70-79.
PDB code: 3dik
18172386 C.H.Liao, Y.Q.Kuang, H.L.Liu, Y.T.Zheng, and B.Su (2007).
A novel fusion gene, TRIM5-Cyclophilin A in the pig-tailed macaque determines its susceptibility to HIV-1 infection.
  AIDS, 21, S19-S26.  
17715216 C.Song, and C.Aiken (2007).
Analysis of human cell heterokaryons demonstrates that target cell restriction of cyclosporine-resistant human immunodeficiency virus type 1 mutants is genetically dominant.
  J Virol, 81, 11946-11956.  
  17963512 D.M.Lang (2007).
Imperfect DNA mirror repeats in the gag gene of HIV-1 (HXB2) identify key functional domains and coincide with protein structural elements in each of the mature proteins.
  Virol J, 4, 113.  
17265140 E.Burkala, and M.Poss (2007).
Evolution of feline immunodeficiency virus Gag proteins.
  Virus Genes, 35, 251-264.  
17920096 F.Diaz-Griffero, A.Kar, M.Lee, M.Stremlau, E.Poeschla, and J.Sodroski (2007).
Comparative requirements for the restriction of retrovirus infection by TRIM5alpha and TRIMCyp.
  Virology, 369, 400-410.  
17574642 H.Javanbakht, F.Diaz-Griffero, W.Yuan, D.F.Yeung, X.Li, B.Song, and J.Sodroski (2007).
The ability of multimerized cyclophilin A to restrict retrovirus infection.
  Virology, 367, 19-29.  
16956947 J.Luban (2007).
Cyclophilin A, TRIM5, and resistance to human immunodeficiency virus type 1 infection.
  J Virol, 81, 1054-1061.  
17526561 L.A.Alcaraz, M.del Alamo, F.N.Barrera, M.G.Mateu, and J.L.Neira (2007).
Flexibility in HIV-1 assembly subunits: solution structure of the monomeric C-terminal domain of the capsid protein.
  Biophys J, 93, 1264-1276.
PDB code: 2jo0
17442718 L.S.Larsen, M.Zhang, N.Beliakova-Bethell, V.Bilanchone, A.Lamsa, K.Nagashima, R.Najdi, K.Kosaka, V.Kovacevic, J.Cheng, P.Baldi, G.W.Hatfield, and S.Sandmeyer (2007).
Ty3 capsid mutations reveal early and late functions of the amino-terminal domain.
  J Virol, 81, 6957-6972.  
17728232 M.A.Brockman, A.Schneidewind, M.Lahaie, A.Schmidt, T.Miura, I.Desouza, F.Ryvkin, C.A.Derdeyn, S.Allen, E.Hunter, J.Mulenga, P.A.Goepfert, B.D.Walker, and T.M.Allen (2007).
Escape and compensation from early HLA-B57-mediated cytotoxic T-lymphocyte pressure on human immunodeficiency virus type 1 Gag alter capsid interactions with cyclophilin A.
  J Virol, 81, 12608-12618.  
17299408 M.A.Rits, K.A.van Dort, C.Münk, A.B.Meijer, and N.A.Kootstra (2007).
Efficient transduction of simian cells by HIV-1-based lentiviral vectors that contain mutations in the capsid protein.
  Mol Ther, 15, 930-937.  
17855544 M.R.Auerbach, K.R.Brown, and I.R.Singh (2007).
Mutational analysis of the N-terminal domain of Moloney murine leukemia virus capsid protein.
  J Virol, 81, 12337-12347.  
17470909 N.Satija, and S.K.Lal (2007).
The molecular biology of SARS coronavirus.
  Ann N Y Acad Sci, 1102, 26-38.  
17590083 P.An, L.H.Wang, H.Hutcheson-Dilks, G.Nelson, S.Donfield, J.J.Goedert, C.R.Rinaldo, S.Buchbinder, G.D.Kirk, S.J.O'Brien, and C.A.Winkler (2007).
Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS.
  PLoS Pathog, 3, e88.  
17225137 P.Mark, and L.Nilsson (2007).
A molecular dynamics study of Cyclophilin A free and in complex with the Ala-Pro dipeptide.
  Eur Biophys J, 36, 213-224.  
17267487 R.Yang, and C.Aiken (2007).
A mutation in alpha helix 3 of CA renders human immunodeficiency virus type 1 cyclosporin A resistant and dependent: rescue by a second-site substitution in a distal region of CA.
  J Virol, 81, 3749-3756.  
17097677 S.A.Datta, J.E.Curtis, W.Ratcliff, P.K.Clark, R.M.Crist, J.Lebowitz, S.Krueger, and A.Rein (2007).
Conformation of the HIV-1 Gag protein in solution.
  J Mol Biol, 365, 812-824.  
17098251 S.A.Datta, Z.Zhao, P.K.Clark, S.Tarasov, J.N.Alexandratos, S.J.Campbell, M.Kvaratskhelia, J.Lebowitz, and A.Rein (2007).
Interactions between HIV-1 Gag molecules in solution: an inositol phosphate-mediated switch.
  J Mol Biol, 365, 799-811.  
  17903253 S.Abdurahman, M.Youssefi, S.Höglund, and A.Vahlne (2007).
Characterization of the invariable residue 51 mutations of human immunodeficiency virus type 1 capsid protein on in vitro CA assembly and infectivity.
  Retrovirology, 4, 69.  
  17371591 S.Abdurahman, S.Höglund, A.Höglund, and A.Vahlne (2007).
Mutation in the loop C-terminal to the cyclophilin A binding site of HIV-1 capsid protein disrupts proper virus assembly and infectivity.
  Retrovirology, 4, 19.  
17449029 S.Chen, X.Zhao, J.Tan, H.Lu, Z.Qi, Q.Huang, X.Zeng, M.Zhang, S.Jiang, H.Jiang, and L.Yu (2007).
Structure-based identification of small molecule compounds targeting cell cyclophilin A with anti-HIV-1 activity.
  Eur J Pharmacol, 565, 54-59.  
17121793 X.G.Yu, M.Lichterfeld, S.Chetty, K.L.Williams, S.K.Mui, T.Miura, N.Frahm, M.E.Feeney, Y.Tang, F.Pereyra, M.X.Labute, K.Pfafferott, A.Leslie, H.Crawford, R.Allgaier, W.Hildebrand, R.Kaslow, C.Brander, T.M.Allen, E.S.Rosenberg, P.Kiepiela, M.Vajpayee, P.A.Goepfert, M.Altfeld, P.J.Goulder, and B.D.Walker (2007).
Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes.
  J Virol, 81, 1619-1631.  
17543365 X.Li, B.Song, S.H.Xiang, and J.Sodroski (2007).
Functional interplay between the B-box 2 and the B30.2(SPRY) domains of TRIM5alpha.
  Virology, 366, 234-244.  
16873251 A.Joshi, K.Nagashima, and E.O.Freed (2006).
Mutation of dileucine-like motifs in the human immunodeficiency virus type 1 capsid disrupts virus assembly, gag-gag interactions, gag-membrane binding, and virion maturation.
  J Virol, 80, 7939-7951.  
16956950 C.S.Adamson, S.D.Ablan, I.Boeras, R.Goila-Gaur, F.Soheilian, K.Nagashima, F.Li, K.Salzwedel, M.Sakalian, C.T.Wild, and E.O.Freed (2006).
In vitro resistance to the human immunodeficiency virus type 1 maturation inhibitor PA-457 (Bevirimat).
  J Virol, 80, 10957-10971.  
17075133 D.Trzesniak, and W.F.van Gunsteren (2006).
Catalytic mechanism of cyclophilin as observed in molecular dynamics simulations: pathway prediction and reconciliation of X-ray crystallographic and NMR solution data.
  Protein Sci, 15, 2544-2551.  
16815734 E.Sokolskaja, and J.Luban (2006).
Cyclophilin, TRIM5, and innate immunity to HIV-1.
  Curr Opin Microbiol, 9, 404-408.  
16501094 E.Sokolskaja, L.Berthoux, and J.Luban (2006).
Cyclophilin A and TRIM5alpha independently regulate human immunodeficiency virus type 1 infectivity in human cells.
  J Virol, 80, 2855-2862.  
16508195 F.Wang, J.Chen, X.Liu, X.Shen, X.He, H.Jiang, and D.Bai (2006).
Synthesis and peptidyl-prolyl isomerase inhibitory activity of quinoxalines as ligands of cyclophilin A.
  Chem Pharm Bull (Tokyo), 54, 372-376.  
16968222 G.Coaker, G.Zhu, Z.Ding, S.R.Van Doren, and B.Staskawicz (2006).
Eukaryotic cyclophilin as a molecular switch for effector activation.
  Mol Microbiol, 61, 1485-1496.  
16275650 H.Gatanaga, D.Das, Y.Suzuki, D.D.Yeh, K.A.Hussain, A.K.Ghosh, and H.Mitsuya (2006).
Altered HIV-1 Gag protein interactions with cyclophilin A (CypA) on the acquisition of H219Q and H219P substitutions in the CypA binding loop.
  J Biol Chem, 281, 1241-1250.  
16537629 J.Martinez-Picado, J.G.Prado, E.E.Fry, K.Pfafferott, A.Leslie, S.Chetty, C.Thobakgale, I.Honeyborne, H.Crawford, P.Matthews, T.Pillay, C.Rousseau, J.I.Mullins, C.Brander, B.D.Walker, D.I.Stuart, P.Kiepiela, and P.Goulder (2006).
Fitness cost of escape mutations in p24 Gag in association with control of human immunodeficiency virus type 1.
  J Virol, 80, 3617-3623.  
16501097 M.R.Auerbach, K.R.Brown, A.Kaplan, D.de Las Nueces, and I.R.Singh (2006).
A small loop in the capsid protein of Moloney murine leukemia virus controls assembly of spherical cores.
  J Virol, 80, 2884-2893.  
16522255 O.Perez, and T.J.Hope (2006).
Cellular restriction factors affecting the early stages of HIV replication.
  Curr HIV/AIDS Rep, 3, 20-25.  
16409630 P.K.Agarwal (2006).
Enzymes: An integrated view of structure, dynamics and function.
  Microb Cell Fact, 5, 2.  
16809314 P.Ulbrich, S.Haubova, M.V.Nermut, E.Hunter, M.Rumlova, and T.Ruml (2006).
Distinct roles for nucleic acid in in vitro assembly of purified Mason-Pfizer monkey virus CANC proteins.
  J Virol, 80, 7089-7099.  
  17038183 T.Y.Lin, and M.Emerman (2006).
Cyclophilin A interacts with diverse lentiviral capsids.
  Retrovirology, 3, 70.  
16873273 W.W.Yeh, E.M.Cale, P.Jaru-Ampornpan, C.I.Lord, F.W.Peyerl, and N.L.Letvin (2006).
Compensatory substitutions restore normal core assembly in simian immunodeficiency virus isolates with Gag epitope cytotoxic T-lymphocyte escape mutations.
  J Virol, 80, 8168-8177.  
15613315 B.M.Forshey, J.Shi, and C.Aiken (2005).
Structural requirements for recognition of the human immunodeficiency virus type 1 core during host restriction in owl monkey cells.
  J Virol, 79, 869-875.  
16254380 C.C.Mische, H.Javanbakht, B.Song, F.Diaz-Griffero, M.Stremlau, B.Strack, Z.Si, and J.Sodroski (2005).
Retroviral restriction factor TRIM5alpha is a trimer.
  J Virol, 79, 14446-14450.  
15827170 C.Gurer, A.Höglund, S.Höglund, and J.Luban (2005).
ATPgammaS disrupts human immunodeficiency virus type 1 virion core integrity.
  J Virol, 79, 5557-5567.  
15734744 D.Huseby, R.L.Barklis, A.Alfadhli, and E.Barklis (2005).
Assembly of human immunodeficiency virus precursor gag proteins.
  J Biol Chem, 280, 17664-17670.  
16306589 D.T.Saenz, W.Teo, J.C.Olsen, and E.M.Poeschla (2005).
Restriction of feline immunodeficiency virus by Ref1, Lv1, and primate TRIM5alpha proteins.
  J Virol, 79, 15175-15188.  
16041386 F.Ternois, J.Sticht, S.Duquerroy, H.G.Kräusslich, and F.A.Rey (2005).
The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor.
  Nat Struct Mol Biol, 12, 678-682.
PDB code: 2buo
16174436 H.X.Guo, F.Wang, K.Q.Yu, J.Chen, D.L.Bai, K.X.Chen, X.Shen, and H.L.Jiang (2005).
Novel cyclophilin D inhibitors derived from quinoxaline exhibit highly inhibitory activity against rat mitochondrial swelling and Ca2+ uptake/ release.
  Acta Pharmacol Sin, 26, 1201-1211.  
15650173 I.Scholz, B.Arvidson, D.Huseby, and E.Barklis (2005).
Virus particle core defects caused by mutations in the human immunodeficiency virus capsid N-terminal domain.
  J Virol, 79, 1470-1479.  
15845542 K.Piotukh, W.Gu, M.Kofler, D.Labudde, V.Helms, and C.Freund (2005).
Cyclophilin A binds to linear peptide motifs containing a consensus that is present in many human proteins.
  J Biol Chem, 280, 23668-23674.  
16203999 L.Berthoux, S.Sebastian, E.Sokolskaja, and J.Luban (2005).
Cyclophilin A is required for TRIM5{alpha}-mediated resistance to HIV-1 in Old World monkey cells.
  Proc Natl Acad Sci U S A, 102, 14849-14853.  
15735342 L.L.Huang, X.M.Zhao, C.Q.Huang, L.Yu, and Z.X.Xia (2005).
Structure of recombinant human cyclophilin J, a novel member of the cyclophilin family.
  Acta Crystallogr D Biol Crystallogr, 61, 316-321.
PDB code: 1xyh
15626706 M.Bon Homme, C.Carter, and S.Scarlata (2005).
The cysteine residues of HIV-1 capsid regulate oligomerization and cyclophilin A-induced changes.
  Biophys J, 88, 2078-2088.  
16131662 M.C.Lidón-Moya, F.N.Barrera, M.Bueno, R.Pérez-Jiménez, J.Sancho, M.G.Mateu, and J.L.Neira (2005).
An extensive thermodynamic characterization of the dimerization domain of the HIV-1 capsid protein.
  Protein Sci, 14, 2387-2404.  
  16188035 M.L.Vana, A.Chen, P.Boross, I.Weber, D.Colman, E.Barklis, and J.Leis (2005).
Mutations affecting cleavage at the p10-capsid protease cleavage site block Rous sarcoma virus replication.
  Retrovirology, 2, 58.  
16557013 S.Misumi (2005).
[Multiple isoforms of cyclophilin A associated with human immunodeficiency virus type 1]
  Uirusu, 55, 273-279.  
16175175 S.Nisole, J.P.Stoye, and A.Saïb (2005).
TRIM family proteins: retroviral restriction and antiviral defence.
  Nat Rev Microbiol, 3, 799-808.  
15596813 T.Hatziioannou, D.Perez-Caballero, S.Cowan, and P.D.Bieniasz (2005).
Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells.
  J Virol, 79, 176-183.  
16199531 U.Chatterji, M.D.Bobardt, R.Stanfield, R.G.Ptak, L.A.Pallansch, P.A.Ward, M.J.Jones, C.A.Stoddart, P.Scalfaro, J.M.Dumont, K.Besseghir, B.Rosenwirth, and P.A.Gallay (2005).
Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells.
  J Biol Chem, 280, 40293-40300.  
15650204 X.Guo, A.Roldan, J.Hu, M.A.Wainberg, and C.Liang (2005).
Mutation of the SP1 sequence impairs both multimerization and membrane-binding activities of human immunodeficiency virus type 1 Gag.
  J Virol, 79, 1803-1812.  
15956549 Y.G.Kuznetsov, M.Zhang, T.M.Menees, A.McPherson, and S.Sandmeyer (2005).
Investigation by atomic force microscopy of the structure of Ty3 retrotransposon particles.
  J Virol, 79, 8032-8045.  
15331691 A.Stevens, M.Bock, S.Ellis, P.LeTissier, K.N.Bishop, M.W.Yap, W.Taylor, and J.P.Stoye (2004).
Retroviral capsid determinants of Fv1 NB and NR tropism.
  J Virol, 78, 9592-9598.  
14963157 B.K.Ganser-Pornillos, U.K.von Schwedler, K.M.Stray, C.Aiken, and W.I.Sundquist (2004).
Assembly properties of the human immunodeficiency virus type 1 CA protein.
  J Virol, 78, 2545-2552.  
15113921 C.M.Owens, B.Song, M.J.Perron, P.C.Yang, M.Stremlau, and J.Sodroski (2004).
Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid.
  J Virol, 78, 5423-5437.  
14726483 D.Ittig, S.Liu, D.Renneberg, D.Schümperli, and C.J.Leumann (2004).
Nuclear antisense effects in cyclophilin A pre-mRNA splicing by oligonucleotides: a comparison of tricyclo-DNA with LNA.
  Nucleic Acids Res, 32, 346-353.  
15331700 D.Melamed, M.Mark-Danieli, M.Kenan-Eichler, O.Kraus, A.Castiel, N.Laham, T.Pupko, F.Glaser, N.Ben-Tal, and E.Bacharach (2004).
The conserved carboxy terminus of the capsid domain of human immunodeficiency virus type 1 gag protein is important for virion assembly and release.
  J Virol, 78, 9675-9688.  
15452250 E.M.Bennett, A.M.Lever, and J.F.Allen (2004).
Human immunodeficiency virus type 2 Gag interacts specifically with PRP4, a serine-threonine kinase, and inhibits phosphorylation of splicing factor SF2.
  J Virol, 78, 11303-11312.  
15542632 E.Sokolskaja, D.M.Sayah, and J.Luban (2004).
Target cell cyclophilin A modulates human immunodeficiency virus type 1 infectivity.
  J Virol, 78, 12800-12808.  
15469936 F.Yarovinsky, J.F.Andersen, L.R.King, P.Caspar, J.Aliberti, H.Golding, and A.Sher (2004).
Structural determinants of the anti-HIV activity of a CCR5 antagonist derived from Toxoplasma gondii.
  J Biol Chem, 279, 53635-53642.  
15386017 G.B.Mortuza, L.F.Haire, A.Stevens, S.J.Smerdon, J.P.Stoye, and I.A.Taylor (2004).
High-resolution structure of a retroviral capsid hexameric amino-terminal domain.
  Nature, 431, 481-485.
PDB code: 1u7k
15140966 M.Hammarstedt, and H.Garoff (2004).
Passive and active inclusion of host proteins in human immunodeficiency virus type 1 gag particles during budding at the plasma membrane.
  J Virol, 78, 5686-5697.  
15355356 M.Konno, Y.Sano, K.Okudaira, Y.Kawaguchi, Y.Yamagishi-Ohmori, S.Fushinobu, and H.Matsuzawa (2004).
Escherichia coli cyclophilin B binds a highly distorted form of trans-prolyl peptide isomer.
  Eur J Biochem, 271, 3794-3803.
PDB codes: 1j2a 1v9t 1vai
14722296 M.Oshima, D.Muriaux, J.Mirro, K.Nagashima, K.Dryden, M.Yeager, and A.Rein (2004).
Effects of blocking individual maturation cleavages in murine leukemia virus gag.
  J Virol, 78, 1411-1420.  
15152086 M.T.Garzón, M.C.Lidón-Moya, F.N.Barrera, A.Prieto, J.Gómez, M.G.Mateu, and J.L.Neira (2004).
The dimerization domain of the HIV-1 capsid protein binds a capsid protein-derived peptide: a biophysical characterization.
  Protein Sci, 13, 1512-1523.  
15286729 P.J.Goulder, and D.I.Watkins (2004).
HIV and SIV CTL escape: implications for vaccine design.
  Nat Rev Immunol, 4, 630-640.  
15229879 P.K.Agarwal (2004).
Cis/trans isomerization in HIV-1 capsid protein catalyzed by cyclophilin A: insights from computational and theoretical studies.
  Proteins, 56, 449-463.  
15162489 S.Liu, C.Zhang, H.Zhou, and Y.Zhou (2004).
A physical reference state unifies the structure-derived potential of mean force for protein folding and binding.
  Proteins, 56, 93.  
  15169567 S.Nisole, and A.Saïb (2004).
Early steps of retrovirus replicative cycle.
  Retrovirology, 1, 9.  
15568972 S.P.Goff (2004).
Genetic control of retrovirus susceptibility in mammalian cells.
  Annu Rev Genet, 38, 61-85.  
15610729 S.P.Goff (2004).
Retrovirus restriction factors.
  Mol Cell, 16, 849-859.  
15140998 T.Hatziioannou, S.Cowan, U.K.Von Schwedler, W.I.Sundquist, and P.D.Bieniasz (2004).
Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid.
  J Virol, 78, 6005-6012.  
14694086 X.Guo, J.Hu, J.B.Whitney, R.S.Russell, and C.Liang (2004).
Important role for the CA-NC spacer region in the assembly of bovine immunodeficiency virus Gag protein.
  J Virol, 78, 551-560.  
15152006 Y.Morikawa, T.Goto, and F.Momose (2004).
Human immunodeficiency virus type 1 Gag assembly through assembly intermediates.
  J Biol Chem, 279, 31964-31972.  
12805204 B.K.Ganser, A.Cheng, W.I.Sundquist, and M.Yeager (2003).
Three-dimensional structure of the M-MuLV CA protein on a lipid monolayer: a general model for retroviral capsid assembly.
  EMBO J, 22, 2886-2892.  
12730686 B.R.Howard, F.F.Vajdos, S.Li, W.I.Sundquist, and C.P.Hill (2003).
Structural insights into the catalytic mechanism of cyclophilin A.
  Nat Struct Biol, 10, 475-481.
PDB codes: 1m9c 1m9d 1m9e 1m9f 1m9x 1m9y
12477877 C.M.Owens, P.C.Yang, H.Göttlinger, and J.Sodroski (2003).
Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells.
  J Virol, 77, 726-731.  
12881522 K.Zander, M.P.Sherman, U.Tessmer, K.Bruns, V.Wray, A.T.Prechtel, E.Schubert, P.Henklein, J.Luban, J.Neidleman, W.C.Greene, and U.Schubert (2003).
Cyclophilin A interacts with HIV-1 Vpr and is required for its functional expression.
  J Biol Chem, 278, 43202-43213.  
12634401 M.Khan, M.Garcia-Barrio, and M.D.Powell (2003).
Treatment of human immunodeficiency virus type 1 virions depleted of cyclophilin A by natural endogenous reverse transcription restores infectivity.
  J Virol, 77, 4431-4434.  
12761222 M.del Alamo, J.L.Neira, and M.G.Mateu (2003).
Thermodynamic dissection of a low affinity protein-protein interface involved in human immunodeficiency virus assembly.
  J Biol Chem, 278, 27923-27929.  
12829840 S.M.Rue, J.W.Roos, L.M.Amzel, J.E.Clements, and S.A.Barber (2003).
Hydrogen bonding at a conserved threonine in lentivirus capsid is required for virus replication.
  J Virol, 77, 8009-8018.  
14610182 S.Tang, T.Murakami, N.Cheng, A.C.Steven, E.O.Freed, and J.G.Levin (2003).
Human immunodeficiency virus type 1 N-terminal capsid mutants containing cores with abnormally high levels of capsid protein and virtually no reverse transcriptase.
  J Virol, 77, 12592-12602.  
12692245 U.K.von Schwedler, K.M.Stray, J.E.Garrus, and W.I.Sundquist (2003).
Functional surfaces of the human immunodeficiency virus type 1 capsid protein.
  J Virol, 77, 5439-5450.  
11836403 A.C.Saphire, M.D.Bobardt, and P.A.Gallay (2002).
trans-Complementation rescue of cyclophilin A-deficient viruses reveals that the requirement for cyclophilin A in human immunodeficiency virus type 1 replication is independent of its isomerase activity.
  J Virol, 76, 2255-2262.  
11932436 A.C.Saphire, M.D.Bobardt, and P.A.Gallay (2002).
Cyclophilin a plays distinct roles in human immunodeficiency virus type 1 entry and postentry events, as revealed by spinoculation.
  J Virol, 76, 4671-4677.  
11991995 B.M.Forshey, U.von Schwedler, W.I.Sundquist, and C.Aiken (2002).
Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication.
  J Virol, 76, 5667-5677.  
12070326 C.Hetényi, and D.van der Spoel (2002).
Efficient docking of peptides to proteins without prior knowledge of the binding site.
  Protein Sci, 11, 1729-1737.  
12388733 C.Liang, J.Hu, R.S.Russell, A.Roldan, L.Kleiman, and M.A.Wainberg (2002).
Characterization of a putative alpha-helix across the capsid-SP1 boundary that is critical for the multimerization of human immunodeficiency virus type 1 gag.
  J Virol, 76, 11729-11737.  
12032547 C.Tang, Y.Ndassa, and M.F.Summers (2002).
Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein.
  Nat Struct Biol, 9, 537-543.
PDB codes: 1gwp 1l6n
11929983 D.A.Bosco, E.Z.Eisenmesser, S.Pochapsky, W.I.Sundquist, and D.Kern (2002).
Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A.
  Proc Natl Acad Sci U S A, 99, 5247-5252.  
12080334 D.Kern (2002).
Cutting the leash.
  Nat Struct Biol, 9, 496-497.  
11823439 D.S.Horowitz, E.J.Lee, S.A.Mabon, and T.Misteli (2002).
A cyclophilin functions in pre-mRNA splicing.
  EMBO J, 21, 470-480.  
11859194 E.Z.Eisenmesser, D.A.Bosco, M.Akke, and D.Kern (2002).
Enzyme dynamics during catalysis.
  Science, 295, 1520-1523.  
11953462 G.M.Gillespie, R.Kaul, T.Dong, H.B.Yang, T.Rostron, J.J.Bwayo, P.Kiama, T.Peto, F.A.Plummer, A.J.McMichael, and S.L.Rowland-Jones (2002).
Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57.
  AIDS, 16, 961-972.  
12210402 H.C.Chiu, F.D.Wang, S.Y.Yao, and C.T.Wang (2002).
Effects of gag mutations on human immunodeficiency virus type 1 particle assembly, processing, and cyclophilin A incorporation.
  J Med Virol, 68, 156-163.  
11741936 H.Gatanaga, Y.Suzuki, H.Tsang, K.Yoshimura, M.F.Kavlick, K.Nagashima, R.J.Gorelick, S.Mardy, C.Tang, M.F.Summers, and H.Mitsuya (2002).
Amino acid substitutions in Gag protein at non-cleavage sites are indispensable for the development of a high multitude of HIV-1 resistance against protease inhibitors.
  J Biol Chem, 277, 5952-5961.  
12072491 J.Lanman, J.Sexton, M.Sakalian, and P.E.Prevelige (2002).
Kinetic analysis of the role of intersubunit interactions in human immunodeficiency virus type 1 capsid protein assembly in vitro.
  J Virol, 76, 6900-6908.  
12195025 J.P.Stoye (2002).
An intracellular block to primate lentivirus replication.
  Proc Natl Acad Sci U S A, 99, 11549-11551.  
11830645 K.N.Brazin, R.J.Mallis, D.B.Fulton, and A.H.Andreotti (2002).
Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A.
  Proc Natl Acad Sci U S A, 99, 1899-1904.  
12384371 S.Höglund, J.Su, S.S.Reneby, A.Végvári, S.Hjertén, I.M.Sintorn, H.Foster, Y.P.Wu, I.Nyström, and A.Vahlne (2002).
Tripeptide interference with human immunodeficiency virus type 1 morphogenesis.
  Antimicrob Agents Chemother, 46, 3597-3605.  
12208976 S.Misumi, T.Fuchigami, N.Takamune, I.Takahashi, M.Takama, and S.Shoji (2002).
Three isoforms of cyclophilin A associated with human immunodeficiency virus type 1 were found by proteomics by using two-dimensional gel electrophoresis and matrix-assisted laser desorption ionization-time of flight mass spectrometry.
  J Virol, 76, 10000-10008.  
11943775 V.Yurchenko, G.Zybarth, M.O'Connor, W.W.Dai, G.Franchin, T.Hao, H.Guo, H.C.Hung, B.Toole, P.Gallay, B.Sherry, and M.Bukrinsky (2002).
Active site residues of cyclophilin A are crucial for its signaling activity via CD147.
  J Biol Chem, 277, 22959-22965.  
11157057 A.D.Kelleher, C.Long, E.C.Holmes, R.L.Allen, J.Wilson, C.Conlon, C.Workman, S.Shaunak, K.Olson, P.Goulder, C.Brander, G.Ogg, J.S.Sullivan, W.Dyer, I.Jones, A.J.McMichael, S.Rowland-Jones, and R.E.Phillips (2001).
Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses.
  J Exp Med, 193, 375-386.  
11250896 D.Braaten, and J.Luban (2001).
Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells.
  EMBO J, 20, 1300-1309.  
11333909 F.Rayne, F.Bouamr, J.Lalanne, and R.Z.Mamoun (2001).
The NH2-terminal domain of the human T-cell leukemia virus type 1 capsid protein is involved in particle formation.
  J Virol, 75, 5277-5287.  
11222698 F.Yu, S.M.Joshi, Y.M.Ma, R.L.Kingston, M.N.Simon, and V.M.Vogt (2001).
Characterization of Rous sarcoma virus Gag particles assembled in vitro.
  J Virol, 75, 2753-2764.  
11816161 H.G.Göttlinger (2001).
The HIV-1 assembly machine.
  AIDS, 15, S13-S20.  
11435564 J.B.Bowzard, J.W.Wills, and R.C.Craven (2001).
Second-site suppressors of Rous sarcoma virus Ca mutations: evidence for interdomain interactions.
  J Virol, 75, 6850-6856.  
11312344 L.Dietrich, L.S.Ehrlich, T.J.LaGrassa, D.Ebbets-Reed, and C.Carter (2001).
Structural consequences of cyclophilin A binding on maturational refolding in human immunodeficiency virus type 1 capsid protein.
  J Virol, 75, 4721-4733.  
11461996 L.Rong, R.S.Russell, J.Hu, Y.Guan, L.Kleiman, C.Liang, and M.A.Wainberg (2001).
Hydrophobic amino acids in the human immunodeficiency virus type 1 p2 and nucleocapsid proteins can contribute to the rescue of deleted viral RNA packaging signals.
  J Virol, 75, 7230-7243.  
11423440 L.S.Ehrlich, T.Liu, S.Scarlata, B.Chu, and C.A.Carter (2001).
HIV-1 capsid protein forms spherical (immature-like) and tubular (mature-like) particles in vitro: structure switching by pH-induced conformational changes.
  Biophys J, 81, 586-594.  
11581426 M.Fujita, A.Yoshida, M.Miyaura, A.Sakurai, H.Akari, A.H.Koyama, and A.Adachi (2001).
Cyclophilin A-independent replication of a human immunodeficiency virus type 1 isolate carrying a small portion of the simian immunodeficiency virus SIV(MAC) gag capsid region.
  J Virol, 75, 10527-10531.  
11533218 S.D.Parker, J.S.Wall, and E.Hunter (2001).
Analysis of Mason-Pfizer monkey virus Gag particles by scanning transmission electron microscopy.
  J Virol, 75, 9543-9548.  
11533199 S.Tang, T.Murakami, B.E.Agresta, S.Campbell, E.O.Freed, and J.G.Levin (2001).
Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology and are blocked in initiation of reverse transcription in infected cells.
  J Virol, 75, 9357-9366.  
11070000 A.Ohagen, and D.Gabuzda (2000).
Role of Vif in stability of the human immunodeficiency virus type 1 core.
  J Virol, 74, 11055-11066.  
10799589 A.Ono, D.Demirov, and E.O.Freed (2000).
Relationship between human immunodeficiency virus type 1 Gag multimerization and membrane binding.
  J Virol, 74, 5142-5150.  
10620301 G.Zuber, and E.Barklis (2000).
Atomic force microscopy and electron microscopy analysis of retrovirus Gag proteins assembled in vitro on lipid bilayers.
  Biophys J, 78, 373-384.  
10619849 I.Gross, H.Hohenberg, T.Wilk, K.Wiegers, M.Grättinger, B.Müller, S.Fuller, and H.G.Kräusslich (2000).
A conformational switch controlling HIV-1 morphogenesis.
  EMBO J, 19, 103-113.  
10684292 L.C.Laurent, M.N.Olsen, R.A.Crowley, H.Savilahti, and P.O.Brown (2000).
Functional characterization of the human immunodeficiency virus type 1 genome by genetic footprinting.
  J Virol, 74, 2760-2769.  
11058892 M.T.Ivery (2000).
Immunophilins: switched on protein binding domains?
  Med Res Rev, 20, 452-484.  
10873863 R.L.Kingston, T.Fitzon-Ostendorp, E.Z.Eisenmesser, G.W.Schatz, V.M.Vogt, C.B.Post, and M.G.Rossmann (2000).
Structure and self-association of the Rous sarcoma virus capsid protein.
  Structure, 8, 617-628.
PDB codes: 1em9 1eoq
11024160 S.M.Joshi, and V.M.Vogt (2000).
Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli.
  J Virol, 74, 10260-10268.  
11080628 S.Monaco-Malbet, C.Berthet-Colominas, A.Novelli, N.Battaï, N.Piga, V.Cheynet, F.Mallet, and S.Cusack (2000).
Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24.
  Structure, 8, 1069-1077.
PDB codes: 1e6j 1e6o
10581250 A.C.Saphire, M.D.Bobardt, and P.A.Gallay (1999).
Host cyclophilin A mediates HIV-1 attachment to target cells via heparans.
  EMBO J, 18, 6771-6785.  
  10364286 A.Cimarelli, and J.Luban (1999).
Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein.
  J Virol, 73, 5388-5401.  
10064580 C.Berthet-Colominas, S.Monaco, A.Novelli, G.Sibaï, F.Mallet, and S.Cusack (1999).
Head-to-tail dimers and interdomain flexibility revealed by the crystal structure of HIV-1 capsid protein (p24) complexed with a monoclonal antibody Fab.
  EMBO J, 18, 1124-1136.  
10383459 C.Cartier, P.Sivard, C.Tranchat, D.Decimo, C.Desgranges, and V.Boyer (1999).
Identification of three major phosphorylation sites within HIV-1 capsid. Role of phosphorylation during the early steps of infection.
  J Biol Chem, 274, 19434-19440.  
  10400801 C.Liang, L.Rong, Y.Quan, M.Laughrea, L.Kleiman, and M.A.Wainberg (1999).
Mutations within four distinct gag proteins are required to restore replication of human immunodeficiency virus type 1 after deletion mutagenesis within the dimerization initiation site.
  J Virol, 73, 7014-7020.  
10089398 D.K.Worthylake, H.Wang, S.Yoo, W.I.Sundquist, and C.P.Hill (1999).
Structures of the HIV-1 capsid protein dimerization domain at 2.6 A resolution.
  Acta Crystallogr D Biol Crystallogr, 55, 85-92.
PDB codes: 1a43 1baj
10690406 H.Tang, K.L.Kuhen, and F.Wong-Staal (1999).
Lentivirus replication and regulation.
  Annu Rev Genet, 33, 133-170.  
9867817 J.Hani, B.Schelbert, A.Bernhardt, H.Domdey, G.Fischer, K.Wiebauer, and J.U.Rahfeld (1999).
Mutations in a peptidylprolyl-cis/trans-isomerase gene lead to a defect in 3'-end formation of a pre-mRNA in Saccharomyces cerevisiae.
  J Biol Chem, 274, 108-116.  
  9882352 M.Dettenhofer, and X.F.Yu (1999).
Highly purified human immunodeficiency virus type 1 reveals a virtual absence of Vif in virions.
  J Virol, 73, 1460-1467.  
10026140 M.M.Endrich, P.Gehrig, and H.Gehring (1999).
Maturation-induced conformational changes of HIV-1 capsid protein and identification of two high affinity sites for cyclophilins in the C-terminal domain.
  J Biol Chem, 274, 5326-5332.  
10077575 M.Srivastava, M.Cartas, T.A.Rizvi, S.P.Singh, D.Serio, V.S.Kalyanaraman, H.B.Pollard, and A.Srinivasan (1999).
HIV-1 Gag shares a signature motif with annexin (Anx7), which is required for virus replication.
  Proc Natl Acad Sci U S A, 96, 2704-2709.  
  9971810 S.Campbell, and A.Rein (1999).
In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain.
  J Virol, 73, 2270-2279.  
10322217 T.Wilk, and S.D.Fuller (1999).
Towards the structure of the human immunodeficiency virus: divide and conquer.
  Curr Opin Struct Biol, 9, 231-243.  
9759480 A.D.Frankel, and J.A.Young (1998).
HIV-1: fifteen proteins and an RNA.
  Annu Rev Biochem, 67, 1.  
9516405 E.Barklis, J.McDermott, S.Wilkens, S.Fuller, and D.Thompson (1998).
Organization of HIV-1 capsid proteins on a lipid monolayer.
  J Biol Chem, 273, 7177-7180.  
  9573245 I.Gross, H.Hohenberg, C.Huckhagel, and H.G.Kräusslich (1998).
N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles.
  J Virol, 72, 4798-4810.  
  9525604 K.Wiegers, G.Rutter, H.Kottler, U.Tessmer, H.Hohenberg, and H.G.Kräusslich (1998).
Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites.
  J Virol, 72, 2846-2854.  
  9557731 L.B.Kong, D.An, B.Ackerson, J.Canon, O.Rey, I.S.Chen, P.Krogstad, and P.L.Stewart (1998).
Cryoelectron microscopic examination of human immunodeficiency virus type 1 virions with mutations in the cyclophilin A binding loop.
  J Virol, 72, 4403-4407.  
  9658084 L.Yin, D.Braaten, and J.Luban (1998).
Human immunodeficiency virus type 1 replication is modulated by host cyclophilin A expression levels.
  J Virol, 72, 6430-6436.  
  9499062 M.A.Accola, S.Höglund, and H.G.Göttlinger (1998).
A putative alpha-helical structure which overlaps the capsid-p2 boundary in the human immunodeficiency virus type 1 Gag precursor is crucial for viral particle assembly.
  J Virol, 72, 2072-2078.  
9632380 M.Emerman, and M.H.Malim (1998).
HIV-1 regulatory/accessory genes: keys to unraveling viral and host cell biology.
  Science, 280, 1880-1884.  
9636143 M.Yeager, E.M.Wilson-Kubalek, S.G.Weiner, P.O.Brown, and A.Rein (1998).
Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms.
  Proc Natl Acad Sci U S A, 95, 7299-7304.  
  9420260 N.K.Krishna, S.Campbell, V.M.Vogt, and J.W.Wills (1998).
Genetic determinants of Rous sarcoma virus particle size.
  J Virol, 72, 564-577.  
9458036 T.Hunter (1998).
Prolyl isomerases and nuclear function.
  Cell, 92, 141-143.  
9501077 U.K.von Schwedler, T.L.Stemmler, V.Y.Klishko, S.Li, K.H.Albertine, D.R.Davis, and W.I.Sundquist (1998).
Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly.
  EMBO J, 17, 1555-1568.  
9380739 A.A.Bukovsky, A.Weimann, M.A.Accola, and H.G.Göttlinger (1997).
Transfer of the HIV-1 cyclophilin-binding site to simian immunodeficiency virus from Macaca mulatta can confer both cyclosporin sensitivity and cyclosporin dependence.
  Proc Natl Acad Sci U S A, 94, 10943-10948.  
  9261419 B.E.Agresta, and C.A.Carter (1997).
Cyclophilin A-induced alterations of human immunodeficiency virus type 1 CA protein in vitro.
  J Virol, 71, 6921-6927.  
  9315655 C.M.Alarcón, and J.Heitman (1997).
FKBP12 physically and functionally interacts with aspartokinase in Saccharomyces cerevisiae.
  Mol Cell Biol, 17, 5968-5975.  
10398481 D.E.Ott (1997).
Cellular proteins in HIV virions.
  Rev Med Virol, 7, 167-180.  
  9385632 F.F.Vajdos, S.Yoo, M.Houseweart, W.I.Sundquist, and C.P.Hill (1997).
Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV-1 capsid protein.
  Protein Sci, 6, 2297-2307.
PDB codes: 1awq 1awr 1aws 1awt 1awu 1awv
  9362068 K.Dolinski, C.Scholz, R.S.Muir, S.Rospert, F.X.Schmid, M.E.Cardenas, and J.Heitman (1997).
Functions of FKBP12 and mitochondrial cyclophilin active site residues in vitro and in vivo in Saccharomyces cerevisiae.
  Mol Biol Cell, 8, 2267-2280.  
  9261411 K.J.Palmer, W.Tichelaar, N.Myers, N.R.Burns, S.J.Butcher, A.J.Kingsman, S.D.Fuller, and H.R.Saibil (1997).
Cryo-electron microscopy structure of yeast Ty retrotransposon virus-like particles.
  J Virol, 71, 6863-6868.  
9368755 S.D.Fuller, T.Wilk, B.E.Gowen, H.G.Kräusslich, and V.M.Vogt (1997).
Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle.
  Curr Biol, 7, 729-738.  
  9261445 T.Dorfman, A.Weimann, A.Borsetti, C.T.Walsh, and H.G.Göttlinger (1997).
Active-site residues of cyclophilin A are crucial for its incorporation into human immunodeficiency virus type 1 virions.
  J Virol, 71, 7110-7113.  
9346481 T.R.Gamble, S.Yoo, F.F.Vajdos, U.K.von Schwedler, D.K.Worthylake, H.Wang, J.P.McCutcheon, W.I.Sundquist, and C.P.Hill (1997).
Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein.
  Science, 278, 849-853.
PDB codes: 1a8o 1am3 1aum
The most recent references are shown first. Citation data come partly from CiteXplore and partly from an automated harvesting procedure. Note that this is likely to be only a partial list as not all journals are covered by either method. However, we are continually building up the citation data so more and more references will be included with time. Where a reference describes a PDB structure, the PDB codes are shown on the right.